These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3148151)

  • 1. Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin.
    Fletcher PJ
    Psychopharmacology (Berl); 1988; 96(2):237-42. PubMed ID: 3148151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats.
    Dourish CT; Clark ML; Fletcher A; Iversen SD
    Psychopharmacology (Berl); 1989; 97(1):54-8. PubMed ID: 2496427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test.
    Neill JC; Bendotti C; Samanin R
    Eur J Pharmacol; 1990 Nov; 190(1-2):105-12. PubMed ID: 2127571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemic properties of serotonin receptor antagonists.
    Wozniak KM; Linnoila M
    Life Sci; 1991; 49(2):101-9. PubMed ID: 1905770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.
    Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):605-10. PubMed ID: 1906186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin receptor blockade increases food intake and body weight after total gastrectomy in rats.
    Zittel TT; Glatzle J; Weimar T; Kless S; Becker HD; Jehle EC
    J Surg Res; 2002 Aug; 106(2):273-81. PubMed ID: 12175978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
    Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
    Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methysergide and metergoline reduce morphine analgesia with no effect on the development of tolerance in rats.
    Romandini S; Samanin R
    Psychopharmacology (Berl); 1984; 82(1-2):140-2. PubMed ID: 6420824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT receptors in the effect of d-fenfluramine on gastric emptying and feeding behaviour as examined in the runway test.
    Samanin R; Neill JC; Grignaschi G; Padura IM; Bizzi A; Garattini S
    Eur J Pharmacol; 1991 May; 197(1):69-73. PubMed ID: 1909959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
    Blackshear MA; Friedman RL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):125-9. PubMed ID: 6646240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone, serotonin receptor subtype antagonists, and carbohydrate intake in rats.
    Islam AK; Dougherty T; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1994 May; 48(1):193-201. PubMed ID: 8029291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 1. 2-Deoxy-D-glucose.
    Beczkowska IW; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1992 Aug; 42(4):661-70. PubMed ID: 1513847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.
    Ramage AG
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):601-7. PubMed ID: 3149720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.